Ultrasound-guided suprafascial plane block for forearm AVF angioplasty: a motor-sparing, image-standardizable alternative to brachial plexus block in a single-center retrospective comparison
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background Balloon angioplasty for forearm arteriovenous fistula (AVF) often provokes substantial pain during inflation. Objective To compare an ultrasound-guided suprafascial plane block (SFPB) with brachial plexus block (BPB) during forearm AVF percutaneous transluminal angioplasty (PTA), focusing on analgesic effectiveness and safety. Methods Single-center, retrospective comparative study (January 1–December 31, 2025) of consecutive adults with forearm radiocephalic AVFs. SFPB targeted the superficial fascia–deep adipose tissue (SF–DAT) interface after sheath placement and guidewire traversal; BPB was completed before venipuncture. The primary endpoint was peak-inflation pain on the numeric rating scale (NRS, 0–10). Secondary outcomes included rescue analgesia, procedure time, block-related complications, and short-term patency. Results We analyzed SFPB (n=32) and BPB (n=35). The primary endpoint favored BPB (mean peak-inflation NRS 1.54 ± 0.74 vs 2.66 ± 0.85; mean difference −1.12, 95% CI −1.51 to −0.73; p =0.0038). Importantly, SFPB still met the prespecified adequacy threshold in most cases (NRS ≤3 in 87.5%, 28/32) without rescue or conversion and with no transient motor block, whereas BPB produced universal transient motor block and hoarseness in 2 patients. Procedure time did not differ significantly (70.77 ± 37.51 vs 87.49 ± 36.21 min; p =0.0613). One- and three-month primary patency was 100% in both groups. Conclusions SFPB provided clinically adequate, motor-sparing analgesia that is compatible with outpatient workflow, while BPB achieved lower NRS at the expense of motor involvement. These findings support SFPB as a pragmatic, image-standardizable alternative; prospective trials are warranted.